Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.24ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.24ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.24EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.24EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MC.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
MC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MC.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
MC.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
MC.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
MC.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
MC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LB.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LB.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LB.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LB.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LB.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LB.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LP.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LP.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LP.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LP.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LP.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LP.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LP.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LP.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.50.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.50.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.50.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.50.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.50.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.50.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.50.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.50.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used